NASDAQ: CLDXCelldex Therapeutics Revenue
Celldex Therapeutics revenue was $7.02M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.2M, down 63.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLDX annual revenue was $7.0M, with 2% growth year-over-year.
CLDX past revenue growth
How has CLDX's revenue growth performed historically?
Company
1.99%
Industry
511.06%
Market
20.87%
CLDX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLDX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CLDX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
CLDX revenue history
Current Revenue
$7.0M
Current Earnings
-$157.9M
Current Profit Margin
-2,248.8%
Be the first to know when CLDX announces revenue.
CLDX Revenue History By Year
| CLDX Yearly Revenue | CLDX Revenue | CLDX Change | CLDX Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $7.02M | $137.00k | +1.99% |
| 2023-12-31 | $6.88M | $4.53M | +192.02% |
| 2022-12-31 | $2.36M | -$2.29M | -49.32% |
| 2021-12-31 | $4.65M | -$2.77M | -37.30% |
| 2020-12-31 | $7.42M | $3.85M | +107.61% |
| 2019-12-31 | $3.57M | -$5.97M | -62.54% |
| 2018-12-31 | $9.54M | -$3.21M | -25.15% |
| 2017-12-31 | $12.74M | $5.96M | +87.78% |
| 2016-12-31 | $6.79M | $1.31M | +23.83% |
| 2015-12-31 | $5.48M | $1.89M | +52.82% |
| 2014-12-31 | $3.59M | -$525.00k | -12.77% |
| 2013-12-31 | $4.11M | -$7.09M | -63.30% |
| 2012-12-31 | $11.20M | $1.94M | +20.91% |
| 2011-12-31 | $9.27M | -$37.53M | -80.20% |
| 2010-12-31 | $46.79M | $31.61M | +208.25% |
| 2009-12-31 | $15.18M | $7.72M | +103.59% |
| 2008-12-31 | $7.46M | $6.05M | +430.30% |
| 2007-12-31 | $1.41M | $506.82k | +56.36% |
| 2006-12-31 | $899.18k | -$2.19M | -70.88% |
| 2005-12-31 | $3.09M | -$3.77M | -54.97% |
| 2004-12-31 | $6.86M | $2.23M | +48.04% |
| 2003-12-31 | $4.63M | -$2.07M | -30.90% |
| 2002-12-31 | $6.70M | $3.36M | +100.39% |
| 2001-12-31 | $3.35M | $2.58M | +338.40% |
| 2000-12-31 | $763.20k | -$720.30k | -48.55% |
| 1999-12-31 | $1.48M | -$666.90k | -31.01% |
| 1998-12-31 | $2.15M | $958.30k | +80.39% |
| 1997-12-31 | $1.19M | $77.60k | +6.96% |
| 1996-12-31 | $1.11M | -$2.85M | -71.88% |
| 1995-12-31 | $3.96M | -$3.00M | -43.12% |
| 1994-12-31 | $6.97M | N/A | N/A |
Celldex Therapeutics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.